Trimi’s headline prices—$99 per month for compounded semaglutide and $125 for compounded tirzepatide—are among the lowest advertised by online GLP-1 providers. Those figures are accurate only in a specific context: they are monthly equivalents for plans costing $1,188 or $1,500 per year.
The program otherwise uses a relatively straightforward model. One payment generally covers clinician review, compounded medication, injection supplies, ongoing messaging and overnight shipping. Trimi also identifies its clinical network and principal pharmacy partners, which is more transparent than relying on vague references to a “licensed pharmacy.”
Our Trimi review found meaningful strengths for cash-pay patients, but also significant limitations. Compounded medication is not FDA approved, annual plans carry restrictive refund terms, and Trustpilot has withdrawn the company’s rating after removing fake reviews.
Key takeaways
- Trimi offers compounded semaglutide and tirzepatide rather than FDA-approved Wegovy or Zepbound. Prescriptions require review by a clinician licensed in the patient’s state.
- Semaglutide costs $175 month to month or $99 per month with annual prepayment. Tirzepatide costs $235 monthly or $125 per month on an annual plan.
- Medication, clinician access, supplies and shipping are included, with no separate membership charge advertised.
- Trimi identifies Arora Health as its clinician network and VialsRx and GreenwichRx as 503A pharmacy partners.
- Once a clinician issues the prescription, the order generally becomes nonrefundable—even if it has not shipped.
- Trustpilot currently displays no Trimi rating because of a guideline breach and states that it removed multiple fake reviews.
Trimi at a glance
| Category | What we found |
|---|---|
| Care model | Online questionnaire, clinician review, pharmacy fulfillment and continuing portal support |
| Main medications | Compounded injectable semaglutide and tirzepatide |
| Monthly prices | $175 for semaglutide; $235 for tirzepatide |
| Lowest advertised rates | $99 and $125 monthly equivalents with annual prepayment |
| Separate membership | None advertised |
| Insurance | Not billed directly |
| Clinical network | Arora Health |
| Pharmacies | VialsRx and GreenwichRx |
| State coverage | All 50 states advertised |
| Main limitation | Low prices require substantial commitments with limited refund flexibility |
Information checked August 5, 2026. Prices, pharmacy assignments and compounded-medication availability may change.
How does Trimi work?
Patients complete a five- to 10-minute online health questionnaire describing their medical history, current medications and weight-related goals. A clinician in Arora Health’s network reviews the information, generally without requiring a video visit. Completing the assessment does not guarantee approval or a prescription.
If the patient is eligible, the prescription is sent to a compounding pharmacy and shipped to the patient. Trimi advertises regular progress check-ins, dose adjustments and unlimited portal messaging. Its “24/7 support” appears to mean that messages can be submitted at any time; published telephone support hours are 9 a.m. to 6 p.m. Eastern.
What medications does Trimi offer?
The program focuses on once-weekly compounded semaglutide and tirzepatide injections.
These are not Wegovy or Zepbound and are not FDA-approved generic equivalents. A state-licensed 503A pharmacy prepares each product for an individual prescription. The FDA does not review the finished compounded drug for safety, effectiveness or manufacturing quality before it is dispensed.
Trimi’s website generally discloses this distinction. However, its homepage also describes compounded semaglutide as “Same as Wegovy.” The FDA has warned other telehealth marketers that claims implying a compounded product is the same as an approved drug can be false or misleading. That wording should be corrected or qualified more clearly.
How much does Trimi cost?
Trimi’s treatment pages currently list the following plan options.
| Plan | Semaglutide | Tirzepatide |
|---|---|---|
| Monthly | $175 | $235 |
| Three months | $435 total | $597 total |
| Six months | $720 total | $1,050 total |
| 12 months | $1,188 total | $1,500 total |
| Annual monthly equivalent | $99 | $125 |
The annual price may be paid upfront or through an outside installment provider. It should not be interpreted as a flexible $99 or $125 monthly subscription. Trimi says medically necessary dose increases do not change the plan price.
Pricing generally includes:
- The medical assessment and ongoing clinician access
- Compounded medication
- Syringes and related supplies
- Dose adjustments and refills
- Priority or overnight shipping
- Patient-portal access
Trimi does not bill insurance directly. The company accepts HSA and FSA payments and says it can provide receipts, but reimbursement depends on the patient’s plan.
Clinician and pharmacy transparency
Trimi publicly identifies Arora Health as its clinical network and Sean Arora, MD, as medical director. Its provider page says each prescription is reviewed by a clinician licensed in the patient’s state.
The company names VialsRx and GreenwichRx as its 503A sterile-compounding partners. A Texas Board of Pharmacy document confirms license number 35264 for VialsRx. Trimi also says certificates of analysis are available on request, although patients should request documentation for the pharmacy and batch involved in their own prescription.
Naming the pharmacy is a positive trust signal. It does not mean the FDA has approved the pharmacy’s compounded products.
Refunds and cancellation require close attention
Trimi allows a full refund if the patient cancels before a clinician issues the prescription or if the clinician determines treatment is inappropriate. Once the prescription has been issued, the order is considered final—even if the medication is still being prepared or has not shipped.
Multi-month plans are not ordinarily prorated. Early exits from discounted six- or 12-month plans are reviewed case by case, so “cancel anytime” principally means stopping future renewals rather than recovering the unused value of a prepaid plan.
Trimi also publishes a six-month money-back promise. To qualify under the no-results provision, members must complete six continuous months, follow the prescribed plan, attend check-ins and log both starting and six-month weights. The request must be submitted within 30 days of the six-month mark.
Reputation and consumer-review concerns
Trimi promotes ratings of 4.8 or 4.9 “across thousands of patients” and reproduces favorable Reddit comments on its treatment pages. The source and verification method for the broader numerical ratings are not clearly identified.
Trustpilot provides a more cautionary signal. Its Trimi profile currently has no available rating because of a guideline breach, and Trustpilot states that it removed multiple fake reviews. The remaining 62 reviews are highly polarized, with 44% awarding five stars and 48% awarding one star at the time checked. Complaints are allegations rather than verified clinical findings, but recurring concerns include refunds, communication, dosing instructions and annual-plan disputes.
Potential benefits
Trimi may appeal because it offers:
- Competitive cash-pay pricing
- No separate membership fee
- Flat pricing at higher doses
- Named clinician and pharmacy partners
- Nationwide access as advertised
- Included supplies and expedited shipping
- Continuing provider messaging
- A detailed refund and satisfaction policy
Meaningful limitations
The main tradeoffs are:
- Compounded products are not FDA approved
- The lowest rates require annual financial commitments
- Prescriptions become nonrefundable very early
- Insurance and prior-authorization support are limited
- Video consultations are not routinely required
- Independent consumer feedback is sharply divided
- Trustpilot has identified fake-review activity
- Some product-comparison language is stronger than current FDA guidance supports
- Federal restrictions may affect future compounded GLP-1 availability
The FDA says semaglutide and tirzepatide shortages have resolved and reminds 503A pharmacies that they generally cannot regularly produce products that are essentially copies of commercially available drugs unless applicable patient-specific conditions are met.
Safety and eligibility considerations
Common adverse effects associated with approved semaglutide and tirzepatide products include nausea, vomiting, diarrhea, constipation and abdominal discomfort. Their labeling also warns about pancreatitis, gallbladder disease, kidney injury related to dehydration, severe gastrointestinal reactions and serious allergic responses.
Both approved products carry boxed warnings concerning thyroid C-cell tumors observed in animals and are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Pregnancy, concurrent diabetes medication and significant digestive disease also require individualized review.
Compounded vials create an additional possibility of dosing error because concentrations and syringe-unit markings can vary. The FDA has received reports of adverse events and hospitalizations linked to incorrect compounded-semiglutide dosing.
Who may find Trimi worth considering?
Trimi may be worth considering for adults who expect to pay cash, accept the limitations of compounded treatment and are comfortable making a longer financial commitment for a lower effective price.
It may not suit people who want only FDA-approved medication, require insurance authorization, prefer live consultations or want the flexibility to leave an annual plan with a guaranteed prorated refund.
Questions to ask before enrolling
- Which pharmacy will fill my individual prescription?
- What ingredients and concentration will be in the vial?
- Why is compounded treatment appropriate for my needs?
- How often will medication ship under an annual plan?
- What portion of my prepayment is refundable if I stop early?
- Are laboratory tests required?
- How quickly does a clinician answer side-effect questions?
- Can I review the certificate of analysis for my medication?
- What weight and adherence records are required for the guarantee?
- What happens if compounding regulations affect availability?
Final assessment
Trimi has several characteristics consumers should look for in an online program: licensed-provider review, named pharmacy partners, clear dose-independent pricing and a written refund policy. Its month-to-month plans are straightforward, while its annual prices are highly competitive.
The strongest concerns involve the size of the prepaid commitment and the limited opportunity to recover unused funds once a prescription has been issued. The Trustpilot warning and unexplained on-site rating claims also weaken confidence in its reputation marketing.
Trimi may be a practical option for a carefully screened cash-pay patient who understands compounded medication and receives clear written terms before enrolling. The $99 and $125 advertisements should be evaluated as annual commitments—not standalone monthly prices.
Frequently asked questions
Is Trimi legitimate?
Trimi is an identifiable telehealth platform using a named clinician network and state-licensed pharmacy partners. Prescriptions require review by a provider licensed in the patient’s state. This does not mean Trimi or its compounded products are FDA approved.
Does Trimi really cost $99 per month?
The $99 figure is the monthly equivalent of a $1,188 annual semaglutide plan. Month-to-month semaglutide costs $175. Tirzepatide costs $235 monthly or $1,500 annually, equivalent to $125 per month.
Does Trimi include medication?
Yes. Compounded-plan pricing generally includes medication, clinician oversight, supplies, refills and shipping.
Does Trimi accept insurance?
Trimi does not bill insurance directly. HSA and FSA payments are accepted, and receipts may be available for possible reimbursement.
Is Trimi’s medication FDA approved?
No. Its principal semaglutide and tirzepatide products are patient-specific compounded preparations. The FDA has approved branded products containing those ingredients, but not Trimi’s finished compounded medications.
Can I cancel Trimi?
You can stop future treatment, but a prescription becomes nonrefundable once issued. Discounted multi-month plans are generally not prorated, and requests to leave early are considered case by case.
